In clinical publications, CS10 (CagriSema) is described as a combination acting simultaneously on two independent satiety mechanisms
Limitations of this approach, however, include the lack of quantitative analysis and of a structured assessment of the quality of studies and certainty of evidence, which were beyond the scope of this descriptive work
Lancet Oncol 10:653662 Aminian A, Wilson R, Al-Kurd A et al (2022) Association of bariatric surgery with cancer risk and mortality in adults with obesity
Insurance companies, employers, Medicare, literally don't have the budget right now to fund all the demand for these drugs
After a thorough evaluation, we provide guidance on the best treatment plan, combining GLP-1 therapy with hormone replacement therapy (HRT) and other solutions for lasting results
This one is from my own field, and it still stings